IMP
Process View
negative regulation of bile acid biosynthetic process
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of bile acids.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of bile acid biosynthetic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 1.000 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 1.000 | ||
| RXRA | retinoid X receptor, alpha | 1.000 | ||
| RARA | retinoic acid receptor, alpha | 0.998 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.992 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.974 | ||
| HR | hairless homolog (mouse) | 0.884 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.840 | ||
| RUNX1 | runt-related transcription factor 1 | 0.602 | ||
| MED25 | mediator complex subunit 25 | 0.569 | ||
| KLB | klotho beta | 0.567 | ||
| CHD9 | chromodomain helicase DNA binding protein 9 | 0.558 | ||
| PGR | progesterone receptor | 0.348 | ||
| ESR1 | estrogen receptor 1 | 0.296 | ||
| HDAC3 | histone deacetylase 3 | 0.277 | ||
| ESRRG | estrogen-related receptor gamma | 0.261 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.187 | Human | |
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.166 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.132 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.128 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.125 | Human | |
| SP1 | Sp1 transcription factor | 0.110 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.099 | ||
| EP300 | E1A binding protein p300 | 0.098 | ||
| NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.083 | ||
| SKIL | SKI-like oncogene | 0.078 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.057 | ||
| NR1I2 | nuclear receptor subfamily 1, group I, member 2 | 0.052 | Human | |
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.046 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.038 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.036 | Human | |
| CREBBP | CREB binding protein | 0.032 | ||
| NR1I3 | nuclear receptor subfamily 1, group I, member 3 | 0.030 | Human | |
| SMARCC2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 | 0.025 | ||
| THRB | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) | 0.024 | ||
| ACVR1B | activin A receptor, type IB | 0.023 | ||
| NR1H3 | nuclear receptor subfamily 1, group H, member 3 | 0.022 | ||
| CTBP2 | C-terminal binding protein 2 | 0.021 | ||
| SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 0.020 | ||
| HNF1A | HNF1 homeobox A | 0.020 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.020 | ||
| SNW1 | SNW domain containing 1 | 0.019 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.019 | ||
| HDAC10 | histone deacetylase 10 | 0.019 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.019 | ||
| DHX30 | DEAH (Asp-Glu-Ala-His) box polypeptide 30 | 0.018 | ||
| PML | promyelocytic leukemia | 0.016 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.016 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.014 | ||
| HDAC4 | histone deacetylase 4 | 0.014 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.013 | ||
| ATXN1L | ataxin 1-like | 0.013 | ||
| PROX1 | prospero homeobox 1 | 0.013 | ||
| CCND3 | cyclin D3 | 0.013 | ||
| THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.011 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.010 |